Enoxakan 40 Injection
Marketer
Fab Critical Care
Salt Composition
Enoxaparin (40mg)
Overview Enoxakan 40 Injection
Enoxakan 40 Injection is an anticoagulant medication preventing and treating dangerous blood clots. It inhibits clot growth and formation. This injection is beneficial in preventing venous blood clots, specifically deep vein thrombosis and pulmonary embolism. Administered subcutaneously by a healthcare professional (never intramuscularly), dosage and treatment duration depend on individual factors like medical history, response to treatment, the condition being addressed, age, and weight. Continued use is crucial, even without noticeable symptoms, as it proactively mitigates future risks; discontinuation may lead to clot formation. Patients should minimize activities increasing bleeding or injury risk. Common side effects include injection site discomfort, hemorrhage, headache, thrombocytosis, respiratory issues, swelling (edema), anemia, pyrexia, diarrhea, and elevated liver enzymes. Severe headache may indicate intracranial bleeding; intense abdominal pain might signal gastrointestinal bleeding. Bleeding, potentially subtle, poses a significant risk; monitor for symptoms and report concerns promptly. Prior to use, disclose conditions like hypertension, diabetes, or recent cerebrovascular accident. Contraindicated in active bleeding, inform your doctor of all other medications for compatibility assessment. Low body weight elevates bleeding risk, and alcohol consumption further increases the potential for stomach bleeding.
Uses of Enoxakan 40 Injection
Preventing and managing blood clot formation.
Major Benefits of Enoxakan 40 Injection:
Administering this medication will be done by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Enoxakan 40 Injection:
- Bleeding
- Headache
- Low blood platelets
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Fever
- Injection site pain
- Breathing problems
- Edema (swelling)
- Diarrhea
How to use Enoxakan 40 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Enoxakan 40 Injection works:
Enoxaparin 40 mg injection is a medication that thins the blood. Its mechanism of action involves neutralizing specific coagulation factors, thus hindering clot development and averting vascular obstructions.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Enoxakan 40 Injection and alcohol consumption: the safety of this combination is unestablished. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Enoxakan 40 Injection during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no harmful consequences for the fetus; nonetheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
During breastfeeding, Enoxakan 40 Injection appears to pose minimal risk. Available human data indicate insignificant danger to the infant. The drug's transfer into breast milk is low, resulting in negligible quantities reaching the baby, thus unlikely to cause harm.
DrivingSAFE
Driving ability is typically unaffected by Enoxaparin 40 Injection.
KidneyCAUTION
For individuals with impaired kidney function, the administration of Enoxakan 40 Injection requires careful monitoring. Dosage modification of Enoxakan 40 Injection might be necessary. A physician's consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Enoxakan 40 Injection's use in individuals with hepatic impairment. Physician consultation is recommended. Patients with pre-existing liver conditions should receive this medication with careful monitoring.
What if you forget to take Enoxakan 40 Injection :
Omit a dose of Enoxakan 40 Injection? Seek your physician's advice.
Facts to Know About Enoxakan 40 Injection
| Label | Value |
|---|---|
| Chemical Classification | Low-molecular-weight heparin |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Actions | Low-molecular-weight heparin (LMWH) |

